JP2016534048A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016534048A5 JP2016534048A5 JP2016522040A JP2016522040A JP2016534048A5 JP 2016534048 A5 JP2016534048 A5 JP 2016534048A5 JP 2016522040 A JP2016522040 A JP 2016522040A JP 2016522040 A JP2016522040 A JP 2016522040A JP 2016534048 A5 JP2016534048 A5 JP 2016534048A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- compound according
- aryl
- alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361887988P | 2013-10-08 | 2013-10-08 | |
| US61/887,988 | 2013-10-08 | ||
| PCT/CA2014/050974 WO2015051458A1 (en) | 2013-10-08 | 2014-10-08 | Non-platimun-based anti-cancer compounds for use in targeted chemotherapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016534048A JP2016534048A (ja) | 2016-11-04 |
| JP2016534048A5 true JP2016534048A5 (enExample) | 2018-02-15 |
| JP6765302B2 JP6765302B2 (ja) | 2020-10-07 |
Family
ID=52812401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016522040A Expired - Fee Related JP6765302B2 (ja) | 2013-10-08 | 2014-10-08 | 標的化化学療法に使用するための非白金ベースの抗がん化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10463662B2 (enExample) |
| EP (2) | EP3578176A1 (enExample) |
| JP (1) | JP6765302B2 (enExample) |
| KR (1) | KR102307387B1 (enExample) |
| CN (2) | CN106232581A (enExample) |
| AU (1) | AU2014334461B2 (enExample) |
| CA (1) | CA2926571C (enExample) |
| WO (1) | WO2015051458A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE057041T2 (hu) | 2015-07-06 | 2022-04-28 | Alkermes Inc | Hiszton deacetiláz hetero-halogén gátlói |
| WO2017007755A1 (en) | 2015-07-06 | 2017-01-12 | Rodin Therapeutics, Inc. | Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase |
| KR102218333B1 (ko) | 2016-06-07 | 2021-02-22 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
| EP3484528B1 (en) | 2016-07-18 | 2020-11-25 | Janssen Pharmaceutica NV | Tau pet imaging ligands |
| HRP20220223T1 (hr) | 2017-01-11 | 2022-04-29 | Alkermes, Inc. | Biciklički inhibitori histon deacetilaze |
| SG11201908820VA (en) | 2017-03-23 | 2019-10-30 | Jacobio Pharmaceuticals Co Ltd | Novel heterocyclic derivatives useful as shp2 inhibitors |
| US11225475B2 (en) | 2017-08-07 | 2022-01-18 | Alkermes, Inc. | Substituted pyridines as inhibitors of histone deacetylase |
| CN112839935A (zh) | 2018-09-26 | 2021-05-25 | 北京加科思新药研发有限公司 | 可用作shp2抑制剂的新型杂环衍生物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3822261A (en) * | 1972-10-30 | 1974-07-02 | Dow Chemical Co | 5,6-dihalo-2-fluoroalkyl-1h-imidazo(4,5-b)pyrazines |
| IL112235A (en) * | 1994-01-03 | 2000-06-29 | Acea Pharm Inc | 1,4-dihydro-pyrido¬2,3-b¾pyrazine-2,3-dione (5 or 8) oxide derivatives and pharmaceutical compositions containing them |
| US7622117B2 (en) * | 2002-04-17 | 2009-11-24 | Dynamis Therapeutics, Inc. | 3-deoxyglucosone and skin |
| DE102004054545A1 (de) * | 2004-09-16 | 2006-04-06 | Max-Delbrück-Centrum für Molekulare Medizin | Änderung des Beladungszustandes von MHC-Molekülen |
| US20060089316A1 (en) * | 2004-10-25 | 2006-04-27 | Brown Truman R | Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof |
| GB0428082D0 (en) | 2004-12-22 | 2005-01-26 | Welcome Trust The Ltd | Therapeutic compounds |
| US7566718B2 (en) * | 2005-02-16 | 2009-07-28 | Schering Corporation | Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| CN101611007A (zh) | 2006-12-20 | 2009-12-23 | 先灵公司 | 新颖的jnk抑制剂 |
| ES2569660T3 (es) * | 2007-06-08 | 2016-05-12 | Mannkind Corporation | Inhibidores de la IRE-1alfa |
| EP2188276B1 (en) * | 2007-08-16 | 2012-03-28 | F. Hoffmann-La Roche AG | Substituted hydantoins |
| DK200801600A (en) * | 2008-11-17 | 2010-05-18 | Engkilde Kaare | Method for treatment of inflammatory diseases |
| EP2493862B1 (en) * | 2009-10-28 | 2016-10-05 | Newlink Genetics Corporation | Imidazole derivatives as ido inhibitors |
| WO2012096813A1 (en) * | 2011-01-11 | 2012-07-19 | Merck Sharp & Dohme Corp. | Imidazole derivatives |
| MX2015008010A (es) | 2012-12-20 | 2016-04-26 | qing-bin Lu | Compuestos radiosensabilizadores para usarse en combinacion con radiacion. |
-
2014
- 2014-10-08 KR KR1020167012036A patent/KR102307387B1/ko not_active Expired - Fee Related
- 2014-10-08 EP EP19188591.2A patent/EP3578176A1/en not_active Withdrawn
- 2014-10-08 CN CN201480066862.2A patent/CN106232581A/zh active Pending
- 2014-10-08 JP JP2016522040A patent/JP6765302B2/ja not_active Expired - Fee Related
- 2014-10-08 WO PCT/CA2014/050974 patent/WO2015051458A1/en not_active Ceased
- 2014-10-08 CA CA2926571A patent/CA2926571C/en active Active
- 2014-10-08 EP EP14852850.8A patent/EP3055287B1/en active Active
- 2014-10-08 AU AU2014334461A patent/AU2014334461B2/en not_active Ceased
- 2014-10-08 CN CN202111465211.9A patent/CN114380700A/zh active Pending
- 2014-10-08 US US15/028,169 patent/US10463662B2/en active Active
-
2019
- 2019-09-18 US US16/574,800 patent/US11446294B2/en active Active